Stroke Prevention articles & resources on Made-in-China.com

U.S. Public Health Efforts Since The 1970s to Get People to Lower Their Blood Pressure

Dec 10, 2013

U.S. public health efforts since the 1970s to get people to lower their blood pressure and quit smoking have helped reduce stroke deaths, researchers say. "The decline in stroke deaths is one of the greatest public health achievements of ...

Tags: Health, Medicine

Atricure Announces FDA Approval to Begin Enrollment in a Clinical Study

Nov 25, 2013

AtriCure, a developer of solutions to treat atrial fibrillation (Afib), has announced the US Food and Drug Administration’s (FDA) approval to begin enrollment in a clinical study of its AtriClip left atrial appendage exclusion system. ...

Tags: AtriCure, Stroke Prevention

CE Mark for New Cardiac Device for Stroke Prevention Is Gained by St Jude Medical

Jan 22, 2013

Medical device manufacturer St. Jude Medical announced that it has gained European CE Mark approval for its AMPLATZER Amulet Left Atrial Appendage Occluder, a new cardiac device that can prevent heart stroke. According to the US-based ...

Tags: Medical, Medical device, Medical cardiovascular

AtriCure Names Michael Carrel as The Company's New President and Chief Executive Officer

Dec 17, 2012

AtriCure, a developer of cardiac surgical ablation systems, has named Michael Carrel as the company's new president and chief executive officer (CEO). Initially, Carrel served at Vital Images, a medical imaging software company, as ...

Tags: management team, new CEO, AtriCure

The European Commission Has Cleared an Oral Anticoagulant, Eliquis

Nov 28, 2012

The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...

Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban

Bayer Oral Anticoagulant Xarelto Has Gained Positive CDR Recommendation

Nov 28, 2012

Bayer oral anticoagulant Xarelto has gained positive common drug review (CDR) recommendation from the Canadian Agency for Drugs and Technologies in Health for the prevention of stroke and systemic embolism in atrial fibrillation (AF) ...

Tags: Bayer oral anticoagulant Xarelto, CDR Recommendation, Stroke Prevention